4 HIV drugs inhibit retrovirus tied to prostate cancer, chronic fatigue

04/1/2010 | Bloomberg Businessweek

U.S. researchers learned that four HIV medicines target the xenotropic murine leukemia virus-related virus, a retrovirus that possibly causes prostate cancer and chronic fatigue syndrome, when administered as combination therapies. The drug cocktails involving raltegravir, zidovudine, tenofovir disoproxil fumarate and a compound labeled L-00870812 "might also have the added benefit of delaying or even preventing the virus from mutating into forms that are drug-resistant," a study author said.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT